PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: rfXcel Corporation

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Thomas J. Pizzuto Joins rfXcel as Vice President of Client Services - Pharmaceutical Industry's most production-proven e-Pedigree solution company adds industry veteran to it's Management Team
Thomas J. Pizzuto Joins rfXcel as Vice President of Client Services

 

NewswireToday - /newswire/ - San Ramon, CA, United States, 2008/02/08 - Pharmaceutical Industry's most production-proven e-Pedigree solution company adds industry veteran to it's Management Team.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

rfXcel, a leading provider of ePedigree Management solutions, today announced that Thomas J. Pizzuto has joined the company as Vice President of Client Services. In this newly created position, Tom will be responsible for managing the company’s consulting and professional services practice.

Tom is a veteran in the Pharmaceutical Industry, joining the company from Wyeth Pharmaceuticals where he was Director, RFID Technology and Strategies. While at Wyeth for 9 years, he was a key contributor and strategist in the creation and ongoing management of Wyeth’s RFID Program Office promoting patient safety, channel security and regulatory compliance by accurately tracking the movement of finished pharmaceutical products through all phases of supply chain management. Tom has served on a variety of industry groups: Tri-chair of the Item Level Tagging Joint Requirements Group for EPCglobal; Steering Committee member of EPC Global Health Care Life Sciences Business Action Group; Steering Committee Chairman of HDMA “ RX Safe Track”; and Technology Team Lead, Secure Supply Chain, for PhRMA. Tom will remain active in the standards development process, representing rfXcel interests at GS1 Healthcare. Prior to Wyeth, Tom held management positions at several companies, including General Electric and Andersen Consulting.

"We’re excited to have a professional of Tom’s caliber on board to assist our customers in developing successful ePedigree and Serialization plans and implementations", said Jim Ensell, President and COO of rfXcel. "Tom brings a wealth of experience to rfXcel and our growing customer base, as well as a strong appreciation for patient safety. His track record of successful execution both inside Wyeth and outside through his industry standards participation is outstanding."

"I’m excited to join rfXcel as the demand grows for its ePedigree Management products and services”, said Pizzuto. “Having been with a leading pharmaceutical company for as long as I have, and having examined the growing challenges associated with ePedigree and Serialization, I’m convinced that the rfXcel solution provides the deepest, most feature rich, easy to use, and production proven system available to meet these challenges. I believe my experience will compliment rfXcel’s product and service offerings and I look forward to applying this combination to help customers throughout the pharmaceutical value chain”.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: rfXcel Corporation

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Thomas J. Pizzuto Joins rfXcel as Vice President of Client Services

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Jim Ensell - rfXcel.com 
925-325-0584 jensell[.]rfxcel.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any rfXcel Corporation securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From rfXcel Corporation / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Genentech’s Cancer Immunotherapy Tecentriq® (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization
Sugar Element of Keratan Sulfate Halts the Progress of Emphysema Finds RIKEN
Exelixis and Ipsen Amend Exclusive Licensing Agreement for the Commercialization and Development of Cabozantinib to Include Canada
FDA Extends Review of Application for OCREVUS™ (Ocrelizumab)
MDxHealth Announces AceCGT Life Science Limited as the Exclusive Distributor for SelectMDx in Hong Kong and Macao China
Pulse Certified As A Level Four Multichannel Content Agency by Veeva Systems
BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics
Sartorius Announces Expansion of Sartorius Stedim Cellca
Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
BD Integrating Technology, Expertise and Services to Provide Comprehensive Medication Management
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  BizJobs.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)